Reviewing Allied Healthcare Products (NASDAQ:AHPI) and Bone Biologics (OTC:BBLG)
Reviewing Allied Healthcare Products (NASDAQ:AHPI) and Bone Biologics (OTC:BBLG)
Allied Healthcare Products (NASDAQ:AHPI – Get Rating) and Bone Biologics (OTC:BBLG – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation and risk.
Allied Healthcare Products（纳斯达克股票代码：AHPI — Get Ratings）和Bone Biologics（场外交易代码：BBLG — 获取评级）都是小型医疗公司，但哪项投资更好？我们将根据两家公司的盈利能力、分析师建议、收益、机构所有权、股息、估值和风险对比这两家公司。
Analyst Ratings
分析师评级
This is a summary of recent ratings and price targets for Allied Healthcare Products and Bone Biologics, as provided by MarketBeat.com.
这是Marketbeat.com提供的Allied Healthcare Products和Bone Biologics的最新评级和目标价格的摘要。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Allied Healthcare Products | 0 | 0 | 0 | 0 | N/A |
| Bone Biologics | 0 | 0 | 1 | 0 | 3.00 |
| 卖出评级 | 保持收视率 | 买入评级 | 强劲的买入评级 | 评分分数 | |
| 联合医疗保健产品 | 0 | 0 | 0 | 0 | 不适用 |
| 骨生物制剂 | 0 | 0 | 1 | 0 | 3.00 |
Bone Biologics has a consensus target price of $2.25, suggesting a potential upside of 806.16%. Given Bone Biologics' higher possible upside, analysts plainly believe Bone Biologics is more favorable than Allied Healthcare Products.
Bone Biologics的共识目标价为2.25美元，这表明潜在的上涨空间为806.16％。鉴于Bone Biologics可能有更高的上行空间，分析师显然认为Bone Biologics比Allied Healthcare Product
Volatility and Risk
波动性和风险
Institutional and Insider Ownership
机构所有权和内部所有权
4.2% of Allied Healthcare Products shares are owned by institutional investors. Comparatively, 7.6% of Bone Biologics shares are owned by institutional investors. 5.1% of Allied Healthcare Products shares are owned by insiders. Comparatively, 71.5% of Bone Biologics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
联合医疗产品4.2％的股份由机构投资者持有。相比之下，Bone Biologics的7.6％股票由机构投资者持有。5.1％的Allied Healthcare Products股份由内部人士持有。相比之下，Bone Biologics有71.5％的股份由内部人士持有。强大的机构所有权表明，捐赠基金、大型基金经理和对冲基金认为，从长远来看，股票的表现将超过市场。
Profitability
盈利能力
This table compares Allied Healthcare Products and Bone Biologics' net margins, return on equity and return on assets.
该表比较了Allied Healthcare Products和Bone Biologics的净利润率、股本回报率和资产
| Net Margins | Return on Equity | Return on Assets | |
| Allied Healthcare Products | -19.82% | -70.44% | -31.16% |
| Bone Biologics | N/A | 7,587.33% | 7,258.20% |
| 净利润 | 股本回报率 | 资产回报率 | |
| 联合医疗保健产品 | -19.82% | -70.44% | -31.16% |
| 骨生物制剂 | 不适用 | 7,587.33% | 7,258.20% |
Valuation and Earnings
估值和收益
This table compares Allied Healthcare Products and Bone Biologics' gross revenue, earnings per share (EPS) and valuation.
该表比较了Allied Healthcare Products和Bone Biologics的总收入、每股收益（EPS）和
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Allied Healthcare Products | $27.05 million | 0.15 | -$5.36 million | ($1.34) | -0.75 |
| Bone Biologics | N/A | N/A | -$1.61 million | N/A | N/A |
| 总收入 | 价格/销售比率 | 净收入 | 每股收益 | 市盈率 | |
| 联合医疗保健产品 | 2705 万美元 | 0.15 | -536 万美元 | (1.34 美元) | -0.75 |
| 骨生物制剂 | 不适用 | 不适用 | -161 万美元 | 不适用 | 不适用 |
Bone Biologics has lower revenue, but higher earnings than Allied Healthcare Products.
与联合医疗产品相比，Bone Biologics的收入较低，但收益更高。
Summary
摘要
Bone Biologics beats Allied Healthcare Products on 9 of the 10 factors compared between the two stocks.
与两只股票相比，Bone Biologics在10个因素中的9个因素上击败了Allied Healthcare
About Allied Healthcare Products
关于 Allied 医疗保健产品
(Get Rating)
（获取评分）
Allied Healthcare Products, Inc. manufactures and markets respiratory products for use in the health care industry in a range of hospitals and alternate site settings worldwide. The company offers respiratory care/anesthesia products, including air compressors, calibration equipment, humidifiers, croup tents, and equipment dryers, as well as respiratory disposable products, such as oxygen tubing products, facemasks, cannulas, and ventilator circuits; and home respiratory care products comprising aluminum oxygen cylinders, oxygen regulators, pneumatic nebulizers, portable suction equipment, and a line of respiratory disposable products. It also provides medical gas equipment, which includes construction products consisting of in-wall medical system components, central station pumps and compressors, and headwalls; regulation devices and suction equipment comprising flowmeters, vacuum regulators, and pressure regulators, as well as related adapters, fittings, and hoses that measure, regulate, monitor, and transfer medical gases from walled piping or equipment to patients in hospital rooms, operating theaters, and intensive care areas; and disposable oxygen cylinders to provide oxygen for short periods. In addition, the company offers emergency medical products that include respiratory/resuscitation products, such as demand resuscitation valves, portable resuscitation systems, bag masks and related products, emergency transport ventilators, precision oxygen regulators, minilators, multilators, and humidifiers; and trauma and patient handling products that include spine immobilization products, pneumatic anti-shock garments, and trauma burn kits. It serves hospitals, hospital equipment dealers, hospital construction contractors, home health care dealers, emergency medical products dealers, and others. The company was incorporated in 1979 and is headquartered in St. Louis, Missouri.
Allied Healthcare Products, Inc. 在世界各地的一系列医院和其他场所生产和销售用于医疗保健行业的呼吸产品。该公司提供呼吸护理/麻醉产品，包括空气压缩机、校准设备、加湿器、露营帐篷和设备烘干机，以及呼吸道一次性产品，例如氧气管产品、口罩、套管和呼吸机回路；以及家庭呼吸护理产品，包括铝氧气瓶、氧气调节器、气动雾化器、便携式抽吸设备和一系列呼吸器一次性产品。它还提供医用气体设备，包括由壁挂式医疗系统组件、中央站泵和压缩机以及前壁组成的建筑产品；包括流量计、真空调节器和压力调节器的调节设备和抽吸设备，以及用于测量、调节、监控医用气体并将其从墙壁管道或设备输送到病房、手术室和重症监护区的患者的相关适配器、接头和软管；以及用于短暂提供氧气的一次性氧气瓶经期。此外，该公司还提供紧急医疗产品，包括呼吸/复苏产品，例如按需复苏阀、便携式复苏系统、袋装口罩和相关产品、紧急运输呼吸机、精密氧气调节器、微型器、多路器和加湿器；以及创伤和患者处理产品，包括脊柱固定产品、气动防休克服和创伤烧伤套件。它为医院、医院设备经销商、医院建筑承包商、家庭医疗保健经销商、紧急医疗产品经销商等提供服务。该公司成立于1979年，总部位于密苏里州圣路易斯。
About Bone Biologics
关于 Bone Biologics
(Get Rating)
（获取评分）
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. The company was founded in 2004 and is headquartered in Burlington, Massachusetts.
Bone Biologics Corporation是一家医疗器械公司，专注于使用重组人蛋白在脊柱融合中的骨再生。该公司的NELL-1/DBX是一种组合产品，它是一种骨刺激性重组蛋白，可为骨再生提供靶向特异性控制。它正在开发 NELL-1/DBX 融合设备，用于治疗骨骼成熟的椎间盘退行性疾病患者，其水平与 L4-S1 相同。该公司的平台技术已应用于在脊柱、骨科、普通骨科、整形重建、神经外科、介入放射学和运动医学等外科专业领域提供增强的疗效。它与加州大学洛杉矶分校技术开发小组签订了许可协议，用于脊柱融合应用的 NELL-1 的开发和商业化。该公司成立于 2004 年，总部位于马萨诸塞州伯灵顿。
Receive News & Ratings for Allied Healthcare Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allied Healthcare Products and related companies with MarketBeat.com's FREE daily email newsletter.
每天接收Allied医疗产品的新闻和评级 -在下面输入您的电子邮件地址，即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Allied Healthcare Products及相关公司的最新新闻和分析师评级的简明每日摘要。